FDA Import Refusal 799-3200722-1/21/2 — CIPLA LTD
The FDA refused shipment 799-3200722-1/21/2 from CIPLA LTD (India) on Jul 14, 2021. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 14, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75